Results 111 to 120 of about 15,260 (213)

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

Mitigating simultaneity bias in seaport efficiency measurement [PDF]

open access: yes
Kenneth Løvold Rødseth, Timo Kuosmanen, Rasmus Bøgh Holmen, Mitigating simultaneity bias in seaport efficiency measurement, Transportation Research Part A: Policy and Practice, Volume 192, 2025, 104333, ISSN 0965-8564,Seaport efficiency measurement is ...
Kuosmanen, Timo   +2 more
core   +1 more source

Flow Enabled Target Capture Halbach‐based magnetic enrichment increases circulating tumor cell capture from blood in metastatic cancer patients

open access: yesMolecular Oncology, EarlyView.
Pair‐wise comparison of the CellSearch and FETCH enrichment technologies for circulating tumor cells (CTCs) from metastatic breast, prostate, and small cell lung cancer patients shows an increased capture of CTCs using FETCH enrichment. The clinical implementation of circulating tumor cells (CTCs) as a predictive tool for therapy efficacy in the ...
Michiel Stevens   +6 more
wiley   +1 more source

Prosody of focus in Turkish Sign Language

open access: yesLanguage and Cognition
Prosodic realization of focus has been a widely investigated topic across languages and modalities. Simultaneous focus strategies are intriguing to see how they interact regarding their functional and temporal alignment.
Serpil Karabüklü, Aslı Gürer
doaj   +1 more source

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Circulating microRNA signatures of cachexia and cancer in Canis familiaris as a comparative oncology model for human disease

open access: yesMolecular Oncology, EarlyView.
Circulating microRNAs as biomarkers of cachexia and sex‐specific cancer in senior dogs. In 25 client‐owned dogs, four circulating miRNAs (miR‐15a, miR‐15b, miR‐16, miR‐140) were downregulated in cachexia, with miR‐16 the strongest individual biomarker (AUC = 0.899).
Soon‐Seok Park   +6 more
wiley   +1 more source

CEACAM1 participation in breast cancer progression

open access: yesMolecular Oncology, EarlyView.
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin   +3 more
wiley   +1 more source

Teoria fenomenológica do processo de relaxação dielétrica

open access: yesRevista Brasileira de Ensino de Física
O objetivo deste trabalho é introduzir o conceito de não simultaneidade entre causa e efeito, o que não é muito comum em diversos problemas de física e biologia, mostrando como tratá-los e verificando em que condições os dois modelos conduzem a ...
Renê Robert
doaj   +1 more source

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

open access: yesMolecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas   +16 more
wiley   +1 more source

Crossmodal simultaneity is not transitive

open access: yes, 2007
Machulla TK, Di Luca M, Ernst MO. Crossmodal simultaneity is not transitive. Presented at the 10th Tübinger Wahrnehmungskonferenz (TWK 2007)
Machulla, T.   +5 more
core  

Home - About - Disclaimer - Privacy